A. Gasbarrini
Università Cattolica del Sacro Cuore
Scientific Director of the Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy Director, Internal Medicine and Gastroenterology and Digestive Disease Center (CEMAD), Gemelli Hospital Professor of Internal Medicine, Università Cattolica del Sacro Cuore, Roma, Italy Dean of the Faculty of Medicine and Surgery from 2022 to 2025
- Papers in database
- 9
- Years active
- 2002 – 2025
- Total publications
- 9
- Total citations
- 6
- h-index
- 1
- Health outcomes studied
- 1
Research Areas
- COVID-19 Clinical Research Studies
- Inflammatory Bowel Disease
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Venous Thromboembolism Diagnosis and Management
- Head and Neck Cancer Studies
Health Outcomes Studied
Papers (9)
- 2025Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools.10.3390/ijms26073059
- 2024The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome.10.3390/nu16030400
- 2023Gut-Kidney-Heart: A Novel Trilogy.10.3390/biomedicines11113063
- 2022Gut microbiota in anxiety and depression: Pathogenesis and therapeutics.10.3389/fgstr.2022.1019578
- 2018Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials10.3390/nu10081074
- 2014The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.10.15403/jgld.2014.1121.234.elr
- 2009Bacillus subtilis isolated from the human gastrointestinal tract.10.1016/j.resmic.2008.11.002
- 2005Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis10.1097/00042737-200509000-00011
- 2002Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study10.1111/j.1572-0241.2002.07063.x